Coccidioidomycosis
Clinical trials for Coccidioidomycosis explained in plain language.
Never miss a new study
Get alerted when new Coccidioidomycosis trials appear
Sign up with your email to follow new studies for Coccidioidomycosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill tame fungal infections when standard drugs fail?
Disease control Not yet recruitingThis Phase 2 trial tests an oral antifungal drug called oteseconazole in adults with dimorphic fungal infections, including coccidioidomycosis, blastomycosis, and histoplasmosis. Participants must already be on antifungal therapy but need a different option because standard first…
Matched conditions: COCCIDIOIDOMYCOSIS
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug and better measurement tools aim to tackle severe valley fever
Disease control Not yet recruitingThis phase 2 trial tests an experimental antifungal drug called olorofim in people with a severe, body-wide form of Valley Fever (disseminated coccidioidomycosis) that has not responded to standard treatments. The study also evaluates new questionnaires about symptoms and quality…
Matched conditions: COCCIDIOIDOMYCOSIS
Phase 2 • Sponsor: F2G Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC